Serum Adiponectin and Vaspin Levels in Rheumatoid Arthritis

dc.contributor.authorOzgen, Metin
dc.contributor.authorKoca, Suleyman Serdar
dc.contributor.authorDagli, Necati
dc.contributor.authorBalin, Mehmet
dc.contributor.authorUstundag, Bilal
dc.contributor.authorIsik, Ahmet
dc.date.accessioned2026-08-12T17:30:32Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstractBackground and Aims. The risks of insulin resistance and accelerated atherosclerosis are increased in chronic inflammatory diseases including rheumatoid arthritis (RA). Adipo-(cyto)kines are associated with insulin resistance, atherosclerosis and inflammation. This study aimed to determine serum adiponectin and vaspin levels and their associations with the predictors of atherosclerosis in RA and Behcet's disease (BD). Methods. The study involved 56 patients with RA, 37 patients with BD, and 29 healthy controls (HC). Serum adiponectin and vaspin levels, homeostasis model assessment for insulin resistance (HOMA-IR) index, and common carotid intima-media thickness (IMT) were determined. Results. Serum adiponectin levels in both patient groups and serum vaspin level in only the RA group were higher, whereas serum vaspin level was lower in the active BD sub,group, compared to the RC group. However, adiponectin and vaspin levels were con-elated with neither HOMA-IR index nor IMT in the RA group. Adiponectin level was correlated with DAS-28 and IL-6 level in the RA group, and it was higher in the active BD subgroup than in the inactive BD subgroup and the HC group. Conclusions. Adiponectin and vaspin levels are higher in RA but associated with neither HOMA-IR index nor IMT. Adiponectin is related with disease activity remarks in RA and BD. Therefore, it may be suggested that adiponectin may be involved in the regulation of inflammatory responses in inflammatory diseases. Moreover, in contrast to in RA, vaspin level declines in active BD, and these results suggest that different chronic inflammatory diseases exert different influences on either adipokines. (C) 2010 IMSS. Published by Elsevier Inc.
dc.identifier.doi10.1016/j.arcmed.2010.08.012
dc.identifier.endpage463
dc.identifier.issn0188-4409
dc.identifier.issn1873-5487
dc.identifier.issue6
dc.identifier.orcid0000-0001-6621-2450
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.pmid21044750
dc.identifier.scopus2-s2.0-78049418187
dc.identifier.scopusqualityQ1
dc.identifier.startpage457
dc.identifier.urihttps://doi.org/10.1016/j.arcmed.2010.08.012
dc.identifier.urihttps://hdl.handle.net/11508/56142
dc.identifier.volume41
dc.identifier.wosWOS:000284678700009
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofArchives of Medical Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectRheumatoid arthritis
dc.subjectBehcet's disease
dc.subjectAdiponectin
dc.subjectVaspin
dc.subjectAtherosclerosis
dc.titleSerum Adiponectin and Vaspin Levels in Rheumatoid Arthritis
dc.typeArticle

Dosyalar